Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia

2 vistas
administrator
administrator
08/04/23

In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.

  • categoría

Mostrar más

0 Comentarios Ordenar por

No se encontraron comentarios

Comentarios de Facebook

Hasta la próxima